Search - tctmd.com

Displaying 1 - 20 of 117

Sort: Relevancy | Date

News Daily News

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Michael O'Riordan

December 24, 2018

News Daily News

Listen Up! Bacteria Commonly Found on Physician Stethoscopes

Michael O'Riordan

December 14, 2018

News Daily News

Better TAVR Outcomes With More Experienced Operators: New York Database

Michael O'Riordan

December 12, 2018

News Daily News

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

Michael O'Riordan

December 10, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

News Daily News

Aspirin Should Play Limited Role in Primary Prevention: Review

Michael O'Riordan

November 27, 2018

News Daily News

Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data

Michael O'Riordan

November 26, 2018

News Daily News

PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study

Michael O'Riordan

November 23, 2018

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Daily News

FDA Touts Increased Oversight of Medical Device Makers

Michael O'Riordan

November 22, 2018

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

News Daily News

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

Michael O'Riordan

November 09, 2018

News Daily News

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Michael O'Riordan

November 07, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

Michael O'Riordan

November 06, 2018

News Daily News

Low Incidence of A-fib Seen in Elite Athletes, Including Runners and Triathletes

Michael O'Riordan

November 02, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

Advertisement

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Listen Up! Bacteria Commonly Found on Physician Stethoscopes

Better TAVR Outcomes With More Experienced Operators: New York Database

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Aspirin Should Play Limited Role in Primary Prevention: Review

Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data

PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

FDA Touts Increased Oversight of Medical Device Makers

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

Low Incidence of A-fib Seen in Elite Athletes, Including Runners and Triathletes

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content